The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

“Poorly differentiated” refers to cancer cells that have more abnormalities and look less like normal cancer cells. Poorly differentiated thyroid cancer is uncommon, accounting for fewer than 5% of ...

"well-differentiated" means the cancer cells resemble the normal cells from which they grew. Well-differentiated cancers grow more slowly and have a better prognosis than undifferentiated cancers, ...

A 5-year follow-up of those randomized to receive or not receive radioiodine after thyroidectomy showed nearly the same low ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Introduction: Differentiated thyroid cancer (DTC) is the most common type of endocrine malignancy, with rising incidence over recent decades. Despite a favorable prognosis, DTC management remains ...

Treatment of thyroid nodules and differentiated thyroid cancer can generally be safely postponed until after delivery. As diagnosing thyroid diseases during pregnancy may be difficult, adequate ...

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Medullary thyroid cancer (MTC) is a rare yet aggressive form of thyroid cancer, accounting for 5–10% of all thyroid malignancies but disproportionately ...

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.